Treatment of small cell lung cancer with somatostatin analogs
US5073541A · kind A · utility
39Cited by
12References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 11, 1988 |
| Grant date | Dec 17, 1991 |
| Priority date | — |
| Expiry date | Aug 11, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a mammal suffering from cancer by administering to the mammal somatostatin or an analog thereof, the analog being a hexapeptide analog or higher, in a dosage of at least 25 .mu.g/kg/day.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.